Shuhua Sports Co., Ltd. ("Shuhua Sports", Stock Code: 605299.SH) completed its IPO and listing on the Main Board of the Shanghai Stock Exchange (SSE) on December 15, 2020, offering 50 million shares at CNY 7.72 per share and raising approximately CNY 364 million. The capital raised will be used for the company's "production base project (Phase II)", "R&D center project" and "informatization project".

Shuhua Sports is a professional and scientific sports health solution provider, mainly engaged in the R&D, production, and sales of fitness equipment and display stands. The company sells indoor fitness equipment to individuals, enterprises, and public institutions. They also provide outdoor path products for the government's fitness path projects, the construction of sports facilities at enterprises and public institutions, and other projects. Additionally, Shuhua Sports supplies display stands to renowned domestic and foreign enterprises like Adidas, Anta, and Xtep.

As the Chinese legal adviser to the issuer, and a long-term partner of Shuhua Sports, Jingtian & Gongcheng has served the NEEQ listing, the listing scheme design and execution, as well as the IPO and listing of Shuhua Sports since 2011.

Hefei Lifeon Pharmaceutical Co., Ltd. ("Lifeon Pharmaceutical", Stock Code: 003020.SZ) completed its IPO and listing on the SME Board of the Shenzhen Stock Exchange (SZSE) on December 15, 2020, raising approximately CNY 536 million at CNY 23.13 per share.

Lifeon Pharmaceutical is an innovative pharmaceutical enterprise engaged in the R&D, production, and sales of drug preparations and active pharmaceutical ingredients, as well as the wholesale and retail of drugs and medical devices. Its key products include cardiovascular drugs, digestive system agents, and dermatologic medicine for external use, among others. Because of the quality of its products, the company received numerous honors and certificates including "China Famous Trademark", "National High-tech Enterprise", "ChemPharm Outstanding Hypotensor Brand", "Anhui's Innovative Enterprise", "Anhui First Award for Science and Technology", "Anhui's Provincially-Accredited Corporate Technical Center" and "Anhui Engineering Research Center for Sustained Release of Drugs". It has also ranked among "China's Top 100 ChemPharm Enterprises" for seven consecutive years from 2013 to 2019.

As the legal adviser to the issuer, Jingtian & Gongcheng provided one-stop, end-to-end legal services for the IPO and listing of Lifeon Pharmaceutical, including legal due diligence, investor introduction, IPO scheme design, and listing application.